Industrialising Fill and Finish of Advanced Therapies: the Benefits of Automation
Are you looking to scale-up and automate your bench-side operations? Would you like to take steps to maximise your product yield in the future?
Cell and gene therapies have had tremendous effects on the treatment of previously incurable diseases. Many products are already on the road to commercialisation.
However, after an elaborate manufacturing process, there are still obstacles on the way to fully automating fill and finish in advanced therapies.
Are you looking to scale-up and automate your bench-side operations? Would you like to take steps to maximise your product yield in the future?
Join us as a panel of experts discusses challenges in the development and transfer to industrial manufacturing, final formulation and fill and finish. The panel of industry leaders will also share insights into which specific requirements have to be met to ensure maximum process and product safety.
WHAT TO EXPECT?
Part 1: The panel addresses key challenges associated with industrialising fill and finish in advanced therapies, including:
- Current challenges in upstream viral vector production: how does this impact fill finish operations?
- Formulation aspects and their impact on final fill: process understanding and improvement is key
- Minimizing product loss with smart filling solutions integrated with highly innovative technologies
- Automation of fill and finish from an engineering perspective: from infrastructure to data integrity
- One step further: specific challenges for the fill and finish of cell therapies
Part 2: The panel answers audience questions with an interactive Q&A.
MEET THE PANEL
 |
Nick Dye Principal Engineer, Founder Pharmaceutical Engineering Resources LLC |
 |
Tesfu Mezghebe Senior Manager Regenxbio |
 |
Lars Waldmann Manager Operations Project Leader Drug Product VVS ThermoFisher (Brammerbio) |
 |
Tatiana Nanda Director Program Leader Center for Breakthrough Medicine at Discovery Labs |
 |
Matthias Poslovski Vice President Sales Turnkey OPTIMA pharma |
 |
Andrea Traube
Director Market Development Pharma OPTIMA pharma |
